Legal & General Global Health & Pharmaceuticals Index Trust C Class AccumulationRegister to Unlock Ratings |
Performance History | 30/11/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.2 | 19.6 | 5.0 | -1.9 | 7.8 | |
+/-Cat | -8.3 | 10.2 | 9.7 | 1.2 | 2.9 | |
+/-B’mrk | - | 1.4 | -0.8 | 0.6 | 0.3 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 04/12/2024 | GBX 81.57 | |
Day Change | -0.71% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | Healthcare | |
ISIN | GB00BJ2JPG83 | |
Fund Size (Mil) 30/11/2024 | GBP 1220.50 | |
Share Class Size (Mil) 04/12/2024 | GBP 551.05 | |
Max Initial Charge | - | |
Ongoing Charge 02/05/2024 | 0.20% |
Investment Objective: Legal & General Global Health & Pharmaceuticals Index Trust C Class Accumulation |
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 30/09/2013 | ||
Inception Date 22/02/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Health&Pharmaceutical PR GBP | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Legal & General Global Health & Pharmaceuticals Index Trust C Class Accumulation | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.67 |
UnitedHealth Group Inc | Healthcare | 6.67 |
Johnson & Johnson | Healthcare | 4.97 |
AbbVie Inc | Healthcare | 4.65 |
Novo Nordisk AS Class B | Healthcare | 4.42 |
Increase Decrease New since last portfolio | ||
Legal & General Global Health & Pharmaceuticals Index Trust C Class Accumulation |